Jane Street’s Verona Pharma VRNA Stock Holding History

Jane Street’s Portfolio VRNA Stock Details VRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-88,800	Closed	-$9.48M	–	12513
2025 Q3	$9.48M	Sell	88,800 -146,400	-62%	-$15.3M	﹤0.01%	2496
2025 Q2	$22.2M	Buy	235,200 +135,800	+137%	+$10.1M	﹤0.01%	1352
2025 Q1	$6.31M	Buy	99,400 +74,000	+291%	+$4.43M	﹤0.01%	2581
2024 Q4	$1.18M	Sell	25,400 -16,000	-39%	-$601K	﹤0.01%	5061
2024 Q3	$1.19M	Buy	41,400 +26,200	+172%	+$645K	﹤0.01%	5540
2024 Q2	$220K	Buy	+15,200	New	+$222K	﹤0.01%	8254
2024 Q1	–	Sell	-12,000	Closed	-$239K	–	10164
2023 Q4	$239K	Buy	+12,000	New	+$177K	﹤0.01%	7965
2023 Q3	–	Sell	-153,000	Closed	-$3.23M	–	9478
2023 Q2	$3.23M	Buy	+153,000	New	+$3.26M	﹤0.01%	3368
2023 Q1	–	Sell	-29,700	Closed	-$776K	–	10011
2022 Q4	$776K	Buy	+29,700	New	+$395K	﹤0.01%	5400

Other funds holding VRNA

DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return

Jane Street's VRNA Position: Q4 2025 in Review

Jane Street sold out of Verona Pharma (VRNA) in Q4 2025, closing a stake of 67,828 shares — an estimated $7.24M sold.

Jane Street first reported a position in VRNA in Q2 2017 and held it in 11 quarters. The position peaked at $16.1M in Q2 2025. 1 fund tracked by Wall St. Rank holds VRNA as of Q4 2025.

Jane Street reported no remaining Verona Pharma position as of Q4 2025 after selling out during the quarter.
Jane Street sold 67,828 Verona Pharma shares in Q4 2025, an estimated $7.24M.
Jane Street first reported a position in Verona Pharma in Q2 2017 and held it in 11 quarters.
Jane Street's Verona Pharma position peaked at $16.1M in Q2 2025.
1 fund tracked by Wall St. Rank held Verona Pharma as of Q4 2025.

Based on Jane Street's 13F filing for Q4 2025, filed 12 Feb 2026.